Bloomberg News

Roche Says Commission Extended Avastin Label to Include Xeloda

June 30, 2011

June 30 (Bloomberg) -- Roche Holding AG said the European Commission extended the Avastin metastatic breast cancer label to include combination with Xeloda, according to an e-mailed statement today.

To contact the editor responsible for this story: Simone Meier at smeier@bloomberg.net


American Apparel's Future
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus